APOC3 (rs5128) was linked to higher BMI and an increased risk of dyslipidemia and obesity, with an OR of 4.022 (95% CI, 1.13–14.30) in a Kuwaiti Arab population study [64]. Here, APOC3 is linked to metabolic syndrome.